Table 1 Clinicopathological characteristics of ccRCC patients in relation to KDM4D expression level.
Characteristics | Patients | Tumor KDM4D expression | p-value | ||
|---|---|---|---|---|---|
n | % | Low | High | ||
All patients | 70 | 100 | 43 | 27 | Ā |
Gender | Ā | Ā | Ā | Ā | 0.899 |
Male | 55 | 78.6% | 34 | 21 | Ā |
Female | 15 | 21.4% | 9 | 6 | Ā |
Age (years) | Ā | Ā | Ā | Ā | 0.508 |
ā¤55 | 32 | 45.7% | 21 | 11 | Ā |
>55 | 38 | 54.3% | 22 | 16 | Ā |
TNM stage | Ā | Ā | Ā | Ā | 0.256 |
I+II | 68 | 97.1% | 41 | 27 | Ā |
III+IV | 2 | 2.9% | 2 | 0 | Ā |
pT stage | Ā | Ā | Ā | Ā | 0.256 |
T1ā+āT2 | 68 | 97.1% | 41 | 27 | Ā |
T3ā+āT4 | 2 | 2.9% | 2 | 0 | Ā |
pN stage | Ā | Ā | Ā | Ā | 0 |
N0 | 70 | 100% | 43 | 27 | Ā |
N1 | 0 | 0 | 0 | 0 | Ā |
Pm stage | Ā | Ā | Ā | Ā | 0 |
M0 | 70 | 100% | 43 | 27 | Ā |
M1 | 0 | 0 | 0 | 0 | Ā |
Furman grade | Ā | Ā | Ā | Ā | 0.0118* |
Iā+āII | 57 | 81.4% | 39 | 18 | Ā |
IIIā+āIV | 13 | 18.6% | 4 | 9 | Ā |
Tumor size(cm) | Ā | Ā | Ā | Ā | 0.606 |
ā¤4 | 39 | 55.7% | 25 | 14 | Ā |
>5 | 31 | 44.3% | 18 | 13 | Ā |
Metastasis for surgery | Ā | Ā | Ā | Ā | 0.00475* |
Yes | 16 | 11.4% | 5 | 11 | Ā |
No | 54 | 88.6% | 38 | 16 | Ā |